Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets [Phase 4]

View source ↗

Summary

An exploratory Phase 4 trial is evaluating potassium citrate sustained-release tablets for gout and hyperuricemia. The study is currently recruiting and also li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium citrate sustained-release tablets (potassium citrate sustained-release)

Snippet

Sponsor: Huashan Hospital | Conditions: Hyperuricemia or Gout, Nephrolithiasis | Phase 4 | Status: RECRUITING